Literature DB >> 4817189

Dopamine and serotonin metabolism in hepatic encephalopathy.

A J Knell, A R Davidson, R Williams, B D Kantamaneni, G Curzon.   

Abstract

Patients with stupor or coma from fulminant hepatic failure were found to have high cerebrospinal fluid concentrations of homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA), metabolites of dopamine and serotonin respectively. Excessive amounts of their precursors-phenylalanine and tyrosine and free tryptophan-were found in the patients' plasma. Methionine, which participates in dopamine degradation, was also much increased. Similar disturbances were found in patients suffering an acute exacerbation of chronic encephalopathy. These abnormalities would be consistent with other evidence of an increased turnover of serotonin and possibly dopamine in the brain during hepatic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4817189      PMCID: PMC1633670          DOI: 10.1136/bmj.1.5907.549

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  18 in total

1.  Studies on the free amino acids and related compounds in the tissues of the cat.

Authors:  H H TALLAN; S MOORE; W H STEIN
Journal:  J Biol Chem       Date:  1954-12       Impact factor: 5.157

2.  Observations on the symptomatology and pathogenesis of hepatic coma.

Authors:  J M WALSHE
Journal:  Q J Med       Date:  1951-10

3.  Free tryptophan in plasma and brain tryptophan metabolism.

Authors:  P J Knott; G Curzon
Journal:  Nature       Date:  1972-10-20       Impact factor: 49.962

4.  False neurotransmitters and hepatic failure.

Authors:  J E Fischer; R J Baldessarini
Journal:  Lancet       Date:  1971-07-10       Impact factor: 79.321

5.  A method for the determination of dopa and 3-O-methyldopa in the plasma of Parkinsonian patients.

Authors:  G Curzon; B D Kantamaneni; J Trigwell
Journal:  Clin Chim Acta       Date:  1972-03       Impact factor: 3.786

6.  Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid.

Authors:  J Korf; H M van Praag; J B Sebens
Journal:  Biochem Pharmacol       Date:  1971-03       Impact factor: 5.858

7.  Effect of tryptophan administration on 5HIAA in cerebrospinal fluid in man.

Authors:  D Eccleston; G W Ashcroft; T B Crawford
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-04       Impact factor: 10.154

8.  Effects of L-tryptophan (a natural sedative) on human sleep.

Authors:  R J Wyatt; K Engelman; D J Kupfer; D H Fram; A Sjoerdsma; F Snyder
Journal:  Lancet       Date:  1970-10-24       Impact factor: 79.321

9.  Treatment of hepatic coma by exchange blood transfusion.

Authors:  C Trey; D G Burns; S J Saunders
Journal:  N Engl J Med       Date:  1966-03-03       Impact factor: 91.245

10.  Colorimetric micro-determination of free fatty acids in plasma.

Authors:  S Laurell; G Tibbling
Journal:  Clin Chim Acta       Date:  1967-04       Impact factor: 3.786

View more
  35 in total

1.  Relationships between tryptophan in serum and CSF, and 5-hydroxyindoleacetic acid in CSF of man: effect of cirrhosis of liver and probenecid administration.

Authors:  S N Young; S Lal; T L Sourkes; F Feldmuller; A Aronoff; J B Martin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-04       Impact factor: 10.154

Review 2.  Neurochemistry of hepatic encephalopathy.

Authors:  C O Record
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

3.  On the nature of brain stem disorders in severe head injured patients.

Authors:  C J Vecht; T C van Woerkom; A W Teelken; J M Minderhoud
Journal:  Acta Neurochir (Wien)       Date:  1976       Impact factor: 2.216

4.  Inhibitory neuromodulators do not alter the course of experimental hepatic encephalopathy.

Authors:  D Rzepczynski; L Zieve; S Lindblad
Journal:  Metab Brain Dis       Date:  1988-09       Impact factor: 3.584

5.  Ammonia-induced changes in pancreatic hormones and plasma amino acids in patients with liver cirrhosis.

Authors:  G Marchesini; M Zoli; C Dondi; A Angiolini; A Melli; E Pisi
Journal:  Dig Dis Sci       Date:  1982-05       Impact factor: 3.199

6.  Insulin degradation in hepatic cirrhosis.

Authors:  J Ono; D G Hutson; R S Dombro; R Zeppa; T Katsuki
Journal:  Gastroenterol Jpn       Date:  1984-04

7.  Hypothalamic-pituitary dopaminergic function in hepatic failure in man.

Authors:  S Lal; M Oravec; A Aronoff; M E Kiely; H Guyda; S Solomon; N P Nair
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

8.  [Tryptophan metabolism in liver diseases: a pharmacokinetic and enzymatic study].

Authors:  M Rössle; R Herz; B Klein; W Gerok
Journal:  Klin Wochenschr       Date:  1986-07-01

9.  Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence.

Authors:  C M Banki
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

Review 10.  Tryptamine: a metabolite of tryptophan implicated in various neuropsychiatric disorders.

Authors:  D D Mousseau
Journal:  Metab Brain Dis       Date:  1993-03       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.